Stryker Corp (SYK): Ronda E Stryker , director of Stryker Corp sold 18,000 shares on Jun 28, 2016. The Insider selling transaction was reported by the company on Jun 30, 2016 to the Securities and Exchange Commission. The shares were sold at $117.34 per share for a total value of $2,112,159.50 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 27, 2016, Ronda E Stryker (director) sold 12,000 shares at $116.09 per share price.On Jun 8, 2016, Srikant Datar (director) sold 6,565 shares at $113.90 per share price.Also, On Jun 2, 2016, Timothy J Scannell (Group President) sold 9,945 shares at $110.72 per share price.On Apr 29, 2016, Glenn S Boehnlein (VP, Chief Financial Officer) sold 2,000 shares at $109.61 per share price.
Stryker Corporation: On Wednesday, Jun 29, 2016 heightened volatility was witnessed in Stryker Corporation which led to swings in the share price. The shares opened for trading at $117.02 and hit $118.87 on the upside , eventually ending the session at $118.81, with a gain of 2.46% or 2.85 points. The heightened volatility saw the trading volume jump to 15,45,252 shares. The 52-week high of the share price is $118.87 and the company has a market cap of $44,433 M . The 52-week low of the share price is at $86.68.
Company has been under the radar of several Street Analysts.Stryker Corporation is Initiated by Guggenheim to Buy. The Rating was issued on Jun 9, 2016.Stryker Corporation is Upgraded by Sterne Agee CRT to Buy. Earlier the firm had a rating of Neutral on the company shares. The Rating was issued on Apr 27, 2016.Stryker Corporation is Reiterated by RBC Capital Mkts to Outperform and the brokerage firm has raised the Price Target to $ 120 from a previous price target of $108 .The Rating was issued on Apr 26, 2016.Stryker Corporation is Downgraded by Robert W. Baird to Neutral and the brokerage firm has raised the Price Target to $ 116 from a previous price target of $111 .Earlier the firm had a rating of Outperform on the company shares. The Rating was issued on Apr 13, 2016.Stryker Corporation is Resumed by Barclays to Underweight and the brokerage firm has set the Price Target at $107. The Rating was issued on Apr 11, 2016.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.